277 related articles for article (PubMed ID: 30622973)
1. Identification of Cross-Protective Potential Antigens against Pathogenic
Hisham Y; Ashhab Y
J Immunol Res; 2018; 2018():1474517. PubMed ID: 30622973
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
3. Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology.
Zai X; Yin Y; Guo F; Yang Q; Li R; Li Y; Zhang J; Xu J; Chen W
Vet Res; 2021 Jun; 52(1):75. PubMed ID: 34078437
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
Jalal K; Khan K; Uddin R
Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
[TBL] [Abstract][Full Text] [Related]
6. Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology Approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
OMICS; 2015 Nov; 19(11):722-9. PubMed ID: 26479901
[TBL] [Abstract][Full Text] [Related]
7. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
[TBL] [Abstract][Full Text] [Related]
8. EpitoCore: Mining Conserved Epitope Vaccine Candidates in the Core Proteome of Multiple Bacteria Strains.
Fiuza TS; Lima JPMS; de Souza GA
Front Immunol; 2020; 11():816. PubMed ID: 32431712
[TBL] [Abstract][Full Text] [Related]
9. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
10. Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.
Gomez G; Adams LG; Rice-Ficht A; Ficht TA
Front Cell Infect Microbiol; 2013; 3():17. PubMed ID: 23720712
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Vaccine of a
Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
Front Immunol; 2021; 12():778475. PubMed ID: 34992597
[No Abstract] [Full Text] [Related]
12. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
[TBL] [Abstract][Full Text] [Related]
13. A novel recombinant multi-epitope protein against Brucella melitensis infection.
Yin D; Li L; Song D; Liu Y; Ju W; Song X; Wang J; Pang B; Xu K; Li J
Immunol Lett; 2016 Jul; 175():1-7. PubMed ID: 27133932
[TBL] [Abstract][Full Text] [Related]
14. Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.
He Y
Front Cell Infect Microbiol; 2012; 2():2. PubMed ID: 22919594
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
17. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
Commander NJ; Spencer SA; Wren BW; MacMillan AP
Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
[TBL] [Abstract][Full Text] [Related]
18. Thermostable cross-protective subunit vaccine against Brucella species.
Cherwonogrodzky JW; Barabé ND; Grigat ML; Lee WE; Poirier RT; Jager SJ; Berger BJ
Clin Vaccine Immunol; 2014 Dec; 21(12):1681-8. PubMed ID: 25320267
[TBL] [Abstract][Full Text] [Related]
19. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
20. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
Bundle DR; McGiven J
Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
